FOXC1 and neoplasm: Maheswaran and colleagues had found that mesenchymal cells expressing known EMT regulators, including TGF-β pathway components and the FOXC1 transcription factor, were highly enriched in circulating tumor cells (CTCs) and these mesenchymal CTCs were associated with disease progression (69).